CompletedPhase 2NCT04224571

CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chinese University of Hong Kong
Principal Investigator
Chi Kong LI, Professor
Chinese University of Hong Kong
Intervention
Bortezomib Injection(drug)
Enrollment
208 target
Eligibility
21 years · All sexes
Timeline
20182023

Study locations (1)

Collaborators

Shanghai Children's Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04224571 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials